JPH0940572A - Inhibitor of amylase and composition for inhibiting amylase - Google Patents

Inhibitor of amylase and composition for inhibiting amylase

Info

Publication number
JPH0940572A
JPH0940572A JP7215368A JP21536895A JPH0940572A JP H0940572 A JPH0940572 A JP H0940572A JP 7215368 A JP7215368 A JP 7215368A JP 21536895 A JP21536895 A JP 21536895A JP H0940572 A JPH0940572 A JP H0940572A
Authority
JP
Japan
Prior art keywords
amylase
cinnamomi cortex
deoiling
inhibitor
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP7215368A
Other languages
Japanese (ja)
Inventor
Norio Iida
教雄 飯田
Reiko Ishii
玲子 石井
Yusuke Hakamata
祐輔 袴田
Sonoko Miyamoto
園子 宮本
Hideaki Ozeki
秀明 大関
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lion Corp
Original Assignee
Lion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lion Corp filed Critical Lion Corp
Priority to JP7215368A priority Critical patent/JPH0940572A/en
Publication of JPH0940572A publication Critical patent/JPH0940572A/en
Pending legal-status Critical Current

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain a safe inhibitor of an amylase, containing a substance prepared by carrying out treatments of deoiling and extracting of Cinnamomi Cortex with a hydrous ethanol solution as an active ingredient, having excellent inhibiting actions on the amylase and hardly causing any bitterness or irritant smell peculiar to the Cinnamomi Cortex. SOLUTION: This inhibitor of an amylase contains a treated Cinnamomi Cortex prepared by carrying out treatments of deoiling and extracting of Cinnamomi Cortex with a hydrous ethanol solution as an active ingredient. For example, KANNAN Cinnamomi Cortex prepared from Cinnamomum cassia Blume as an original plant can be used as the Cinnamomi Cortex. Either of the treatments of deoiling and extracting with the hydrous ethanol solution can previously be performed; however, the deoiling can be carried out by the treatment with steam or a solvent. The extracting treatment with the hydrous ethanol solution is preferably performed by using an aqueous solution of ethanol at 50-90vol.% concentration in a weight of 1-5 times based on the Cinnamomi Cortex under heating conditions up to 80 deg.C for 1-5hr. The operations are preferably repeated 2-5 times. When the objective inhibitor is used as a medicinal composition, the daily dose thereof for an adult is preferably 0.5-2,000mg, expressed in terms of the amount of active ingredient at a time and administered three times before a meal.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は、桂皮から得られる
アミラーゼ阻害剤、及び該アミラーゼ阻害剤を含有し、
医薬品又は食品として利用されるアミラーゼ阻害用組成
物に関する。
TECHNICAL FIELD The present invention relates to an amylase inhibitor obtained from cinnamon bark and the amylase inhibitor,
The present invention relates to a composition for amylase inhibition used as a medicine or food.

【0002】[0002]

【従来の技術及び発明が解決しようとする課題】近年、
飽食、過食、グルメといった食生活からくる肥満は若い
女性だけではなく、糖尿病を始めとする成人病との密接
な関係から広範囲な年齢層にとって重要な問題となって
いる。この肥満を解消する手段としては、脂肪を燃焼さ
せるために運動を行ったり、食事制限を行う等の方法が
考えられる。しかし、運動は継続して行うのが難しく、
食事制限も精神的苦痛を伴うのみならず、カロリー計算
等の負担が大きく、これらの方法で肥満を解消するのは
難しい。また、肥満と密接な関係がある糖尿病、胆石等
の成人病は、澱粉等の過剰摂取による血糖上昇が誘因と
なることが多いといわれる。
2. Description of the Related Art In recent years,
Obesity resulting from dietary habits such as satiation, overeating, and gourmet has become an important issue not only for young women but also for a wide range of age groups due to its close relationship with adult diseases such as diabetes. As a means for eliminating this obesity, methods such as exercising to burn fat and restricting diet can be considered. However, exercise is difficult to continue,
It is difficult to eliminate obesity by these methods because not only is dietary restriction accompanied by mental distress, but the burden of calorie calculation is large. In addition, it is said that adult diseases such as diabetes and gallstones which are closely related to obesity are often triggered by an increase in blood sugar due to excessive intake of starch and the like.

【0003】これらのことから、最近、肥満の簡便な予
防及び治療方法として、日本人のエネルギー源の6割を
占める澱粉を始めとする炭水化物の消化を抑える方法が
考えられている。つまり、日本人の食生活の中心である
米、うどん等の澱粉食品を食べる際に、澱粉の消化酵素
であるアミラーゼの活性を阻害するアミラーゼ阻害剤を
服用して澱粉の消化を抑制する方法等が考えられてい
る。
From these things, recently, as a simple prevention and treatment method for obesity, a method of suppressing the digestion of carbohydrates such as starch, which accounts for 60% of the energy source of the Japanese, has been considered. In other words, when eating starch foods such as rice and udon, which are the center of Japanese dietary habits, a method of suppressing the digestion of starch by taking an amylase inhibitor that inhibits the activity of amylase, which is a digestive enzyme of starch, etc. Is being considered.

【0004】このような背景から、肥満の予防及び治療
の有効な手段として、近年アミラーゼ阻害物質が注目を
浴び、主にマメ科の植物を始めとする穀類の種子や微生
物などから得られる各種オリゴ糖(特開昭63−483
02号公報)等にアミラーゼ阻害作用を有する物質が含
有されていることが知られており、これらをダイエット
食品等へ応用することが提案されている。
Against this background, amylase inhibitors have recently attracted attention as effective means for preventing and treating obesity, and various oligosaccharides obtained mainly from seeds of seeds such as legumes and microorganisms and microorganisms. Sugar (JP-A-63-483)
No. 02) and the like contain substances having an amylase inhibitory action, and it has been proposed to apply these substances to diet foods and the like.

【0005】しかし、これらの物質はアミラーゼ阻害作
用の有効性や味の点で問題を有しており、そのほとんど
が未だ実用化の段階までに至っていない。
However, these substances have problems in effectiveness and taste of amylase inhibitory action, and most of them have not reached the stage of practical use.

【0006】本発明は、上記事情に鑑みなされたもの
で、医薬品や食品としての安全性、有効性の点で問題が
なく、しかも服用、飲食する場合に味の点でも問題がな
いアミラーゼ阻害剤及びアミラーゼ阻害用組成物を提供
することを目的とする。
The present invention has been made in view of the above circumstances, and has no problem in terms of safety and effectiveness as a medicine or food, and also has no problem in taste when ingested or eaten or eaten. And an amylase-inhibiting composition.

【0007】[0007]

【課題を解決するための手段及び発明の実施の形態】本
発明者らは上記目的を達成するため鋭意検討した結果、
桂皮に脱油処理及び含水エタノール溶液で抽出処理を行
うことにより得られる物質が優れたアミラーゼ阻害作用
を有し、しかも桂皮に特有の苦みや刺激臭がほとんどな
いことを見い出し、本発明をなすに至った。
Means for Solving the Problems and Modes for Carrying Out the Invention As a result of intensive investigations by the present inventors to achieve the above object,
It was found that the substance obtained by subjecting cinnamon bark to deoiling treatment and extraction process with a water-containing ethanol solution has an excellent amylase inhibitory action, and has almost no bitterness or irritating odor peculiar to cinnamon bark, and forms the present invention I arrived.

【0008】即ち、本発明は桂皮の脱油処理及び含水エ
タノール溶液による抽出処理物を有効成分とすることを
特徴とするアミラーゼ阻害剤、及び医薬品又は食品とし
て利用されるアミラーゼ阻害用組成物であって、上記ア
ミラーゼ阻害剤を有効成分として含有することを特徴と
するアミラーゼ阻害用組成物を提供する。
[0008] That is, the present invention is an amylase inhibitor characterized by deoiling cinnamon bark and an extract treated with a water-containing ethanol solution as an active ingredient, and an amylase inhibitor composition used as a pharmaceutical or food. Thus, there is provided a composition for inhibiting amylase, which comprises the above-mentioned amylase inhibitor as an active ingredient.

【0009】以下、本発明につき更に詳しく説明する
と、本発明において、桂皮としては、Cinnamom
um cassia Blumeを原植物とする広南桂
皮を用いることができるが、その種は特に制限されるも
のではなく、例えば同属近縁種であるセイロン桂皮
(C.zeylanicum Nees)、ベトナム桂
皮(C.obtussifolium Nees)、日
本桂皮(C.sieboldii Meisn)、ジャ
ワ桂皮(C.burmanni Blume)、タイ桂
皮(C.iners Reinw.ex Blume)
等を有効に用いることができる。また、本発明の桂皮と
して、桂皮末を使用することができる。
The present invention will be described in more detail below. In the present invention, the cinnamon is Cinnamom.
Guangnan cinnamon that uses um cassia Blume as a progenitor plant can be used, but the species is not particularly limited. For example, C. zeylanicum Nees, which is a closely related species, and Vietnam cinnamon (C. obtussifolium Nees), Japanese cinnamon (C. sieboldii Meisn), Java cinnamon (C. burmanni Blume), Thai cinnamon (C. iners Reinw. ex Blume)
Etc. can be effectively used. Further, cinnamon powder can be used as the cinnamon of the present invention.

【0010】本発明に適用されるアミラーゼ阻害剤は、
上記桂皮に脱油処理及び含水エタノール抽出処理を施す
ことによって得られる。この場合、両処理の順序に特に
制限はない。
The amylase inhibitor applicable to the present invention is
It is obtained by subjecting the cinnamon bark to a deoiling treatment and a hydrous ethanol extraction treatment. In this case, the order of both processes is not particularly limited.

【0011】以下に本発明の桂皮に施される脱油処理及
び含水エタノール抽出処理をより具体的に説明する。
The deoiling treatment and hydrous ethanol extraction treatment performed on the cinnamon of the present invention will be described in more detail below.

【0012】本発明の桂皮に施される脱油処理は、含水
エタノール溶液による抽出の前に行っても、抽出後に行
ってもよいが、この脱油は、水蒸気処理又はヘキサン、
アセトン、エーテル等の有機溶媒を使用する溶媒処理に
より行うことができる。
The oil removal treatment applied to the cinnamon bark of the present invention may be carried out before or after extraction with a water-containing ethanol solution. This oil removal is carried out by steam treatment or hexane,
It can be performed by solvent treatment using an organic solvent such as acetone or ether.

【0013】より具体的には、脱油処理を水蒸気処理で
行い、その水蒸気処理を含水エタノール抽出処理前に行
う場合であれば、例えば桂皮をその0.5〜10倍重
量、より好ましくは1〜5倍重量の水に浸漬し、その
後、0.5〜24時間、より好ましくは1〜10時間、
水蒸気を導入する方法等を挙げることができる。一方、
水蒸気処理を含水エタノール抽出処理後に行う場合であ
れば、下記に詳述する含水エタノール抽出処理により得
られた桂皮の抽出液の濃縮、乾燥物をその5〜100倍
重量、より好ましくは10〜50倍重量の水に浸漬し、
その後、上記と同様に処理する方法等を挙げることがで
きる。
More specifically, when the deoiling treatment is carried out by steaming and the steaming is carried out before the hydrous ethanol extraction, for example, cinnamon bark is 0.5 to 10 times its weight, more preferably 1 ~ 5 times the weight of water, then 0.5 to 24 hours, more preferably 1 to 10 hours,
Examples thereof include a method of introducing steam. on the other hand,
When the steam treatment is carried out after the hydrous ethanol extraction treatment, the dried and concentrated product of the cinnamon bark extract obtained by the hydrous ethanol extraction treatment described in detail below is 5 to 100 times its weight, more preferably 10 to 50 times. Immerse in double weight of water,
Then, a method of treating in the same manner as described above can be mentioned.

【0014】また、脱油処理をヘキサン等の溶媒処理で
行い、その処理を含水エタノール抽出処理前に行う場合
であれば、桂皮をその0.5〜10倍重量、より好まし
くは1〜5倍重量の溶媒に浸漬し、その後、0.5〜2
4時間、特に1〜10時間の撹拌操作を行う方法等を挙
げることができる。この場合、撹拌操作は、室温におい
て行うこともできるが、30℃以上、特に使用する溶媒
の沸点温度まで加熱して行うと好適である。なお、この
溶媒処理は、1回でもよいが、2〜5回行うことが好ま
しい。一方、溶媒処理を含水エタノール抽出処理後に行
う場合であれば、桂皮の抽出液の濃縮、乾燥物をその5
〜100倍重量、より好ましくは10〜50倍重量の溶
媒に浸漬し、その後、上記と同様に処理する方法等を挙
げることができる。
When the deoiling treatment is carried out by a solvent treatment such as hexane and the treatment is carried out before the water-containing ethanol extraction treatment, the cinnamon bark is 0.5 to 10 times its weight, more preferably 1 to 5 times its weight. Immerse in heavy solvent, then 0.5-2
A method of carrying out a stirring operation for 4 hours, particularly 1 to 10 hours can be mentioned. In this case, the stirring operation can be carried out at room temperature, but it is preferable to carry out heating at 30 ° C. or higher, especially to the boiling temperature of the solvent used. The solvent treatment may be performed once, but is preferably performed 2 to 5 times. On the other hand, if the solvent treatment is performed after the hydrous ethanol extraction treatment, the cinnamon bark extract is concentrated and the dried product is
A method of immersing in a solvent having a weight of 100 to 100 times, more preferably 10 to 50 times, and then treating in the same manner as described above can be mentioned.

【0015】次に、本発明の桂皮に施される含水エタノ
ール抽出処理についてより具体的に説明すると、ここで
使用される含水エタノール溶液としては、溶液全体に対
してエタノールが10〜95容量%、特に50〜90容
量%である水溶液が好適である。後述する実施例に示す
ように、水又はエタノールによる抽出処理では高いアミ
ラーゼ阻害活性を有し、且つ味の点でも良好な物質を得
ることができないのに対し、上記の含水エタノールによ
る抽出処理は、特に脱油処理と組み合わせることによっ
て、本発明の目的抽出物を得るのに効果的である。ま
た、この含水エタノールの使用量は、桂皮に対し0.5
〜10倍重量、より好ましくは1〜5倍重量とすると好
適である。この場合、抽出時間は、好ましくは0.5〜
10時間、より好ましくは1〜5時間である。また、抽
出温度は室温でもよいが、80℃まで加熱して行うこと
が好ましい。この抽出操作は、1回でもよいが、2〜5
回行うことが好ましい。
Next, the water-containing ethanol extraction treatment applied to the cinnamon of the present invention will be described more specifically. The water-containing ethanol solution used here contains 10 to 95% by volume of ethanol based on the whole solution. Particularly, an aqueous solution of 50 to 90% by volume is suitable. As shown in Examples described later, the extraction treatment with water or ethanol has a high amylase inhibitory activity, and while it is not possible to obtain a good substance in terms of taste, the extraction treatment with the above-mentioned hydrous ethanol, In particular, it is effective to obtain the target extract of the present invention by combining with a deoiling treatment. The amount of water-containing ethanol used is 0.5 for cinnamon bark.
The weight is preferably 10 to 10 times, more preferably 1 to 5 times. In this case, the extraction time is preferably 0.5 to
It is 10 hours, more preferably 1 to 5 hours. The extraction temperature may be room temperature, but it is preferable to perform the extraction by heating to 80 ° C. This extraction operation may be performed once, but 2 to 5
It is preferable to carry out the procedure twice.

【0016】上記のように脱油処理及び含水エタノール
抽出処理を行った後、以下の処理を行うことによって本
発明のアミラーゼ阻害剤を得ることができる。
After the deoiling treatment and the hydrous ethanol extraction treatment as described above, the amylase inhibitor of the present invention can be obtained by the following treatments.

【0017】即ち、脱油処理を含水エタノール抽出処理
の前に行った場合は、脱油処理を行った後、濾過処理等
によって水又は有機溶媒を除去し、次いで含水エタノー
ル溶液による抽出を行い、得られた抽出液を濃縮、乾燥
する方法を採用することができる。ここで、抽出液の濃
縮、乾燥は、減圧濃縮、フラッシュ蒸留等の濃縮法や減
圧乾燥(真空乾燥)、凍結乾燥、噴霧乾燥、薄膜乾燥、
熱風乾燥、赤外線乾燥、高周波乾燥等の公知の濃縮、乾
燥法を利用できる。なお、アミラーゼ阻害剤は、抽出液
の含水量が多くなるほど粉末状になり、取扱いやすくな
る。
That is, when the deoiling treatment is carried out before the hydrous ethanol extraction treatment, after the deoiling treatment, water or an organic solvent is removed by a filtration treatment or the like, and then extraction with a hydrous ethanol solution is carried out, A method of concentrating and drying the obtained extract can be adopted. Here, the extraction liquid is concentrated and dried by vacuum concentration, concentration method such as flash distillation, reduced pressure drying (vacuum drying), freeze drying, spray drying, thin film drying,
Known concentration and drying methods such as hot air drying, infrared ray drying, and high frequency drying can be used. In addition, the amylase inhibitor becomes powdery as the water content of the extract increases, and it becomes easier to handle.

【0018】一方、脱油処理を含水エタノール抽出処理
の後に行う場合には、桂皮の抽出液を濃縮、乾燥した濃
縮、乾燥物(固形物)に脱油処理を行った後、濾過処理
等により水又は有機溶媒を除去し、更に上記と同様にし
て乾燥する方法等により、本発明のアミラーゼ阻害剤を
得ることができる。
On the other hand, when the deoiling treatment is performed after the hydrous ethanol extraction treatment, the cinnamon bark extract is concentrated, dried and concentrated, and the dried product (solid matter) is deoiled and then filtered. The amylase inhibitor of the present invention can be obtained by a method of removing water or an organic solvent and further drying in the same manner as above.

【0019】なお、本発明のアミラーゼ阻害剤は、抽出
液等を粉末化したものに限られるものではなく、濃縮エ
キス、希釈液、ペースト状として使用することもでき
る。また、必要に応じて、例えばそのアミラーゼ阻害活
性をより高める等の目的により、更に精製工程を加えて
もよい。
The amylase inhibitor of the present invention is not limited to the one obtained by pulverizing the extract or the like, but may be used as a concentrated extract, a diluent or a paste. Further, if necessary, a purification step may be added for the purpose of, for example, further increasing the amylase inhibitory activity.

【0020】本発明のアミラーゼ阻害剤は、医薬品、医
薬部外品等に用いられている他の薬剤及び製剤上許容し
得る基剤又は食品等を配合することによって、医薬品、
健康食品又は食品等として利用されるアミラーゼ阻害用
組成物とすることができる。
The amylase inhibitor of the present invention contains a drug, other drugs used in quasi-drugs and the like, and a pharmaceutically acceptable base or food.
It can be an amylase-inhibiting composition used as a health food or food.

【0021】本発明のアミラーゼ阻害用組成物を医薬品
として利用する場合、例えば賦形剤、着色剤、滑沢剤、
結合剤、崩壊剤、被覆剤、安定剤、保存剤等を配合する
ことができる。この場合、各成分とアミラーゼ阻害剤と
の配合割合は特に制限されるものではなく、その製剤化
に適した割合を適宜選定することができる。また、これ
らを配合した組成物(医薬品)の製剤の剤型としては、
錠剤、カプセル剤、散剤、細粒剤、顆粒剤等が挙げられ
る。本発明のアミラーゼ阻害剤は、味の点で問題がない
ので、医薬品として利用する際に、味のマスキングの必
要がなく、種々の剤型を自由に選択することができ、そ
の製造に際しても特に特別な処理を必要とすることもな
い。
When the amylase-inhibiting composition of the present invention is used as a medicine, for example, an excipient, a coloring agent, a lubricant,
Binders, disintegrants, coating agents, stabilizers, preservatives and the like can be added. In this case, the mixing ratio of each component and the amylase inhibitor is not particularly limited, and a ratio suitable for formulation thereof can be appropriately selected. In addition, the dosage form of the formulation of the composition (medicine) containing these is
Examples include tablets, capsules, powders, fine granules and granules. Since the amylase inhibitor of the present invention has no problem in terms of taste, it is not necessary to mask the taste when it is used as a drug, and various dosage forms can be freely selected, and particularly in the production thereof. No special processing is required.

【0022】上記医薬品の投与量は病状などによって変
化し、一定したものではないが、通常大人一回当り有効
成分として0.5〜2000mgを一日3回、食前に服
用することが好ましい。
Although the dose of the above-mentioned drug varies depending on the condition of the disease and is not constant, it is usually preferable to take 0.5 to 2000 mg of the active ingredient per adult 3 times a day before meals.

【0023】本発明のアミラーゼ阻害用組成物を食品と
して利用する場合、その種類は、いかなるものであって
もよく、例えばパン,麺,ビスケット,ケーキ等の澱粉
含有食品の他、米と一緒に摂取できるふりかけやソーセ
ージ,ハム,かまぼこ等の副食、ゼリー,プリン等のデ
ザート、ヨーグルト,アイスクリーム,ミルク等の乳製
品、グミ,キャンディ,チョコレート,ガム等の菓子
類、ジュース,ドリンク等の飲料等が挙げられる。
When the amylase-inhibiting composition of the present invention is used as a food, it may be of any kind. For example, in addition to starch-containing foods such as bread, noodles, biscuits, cakes, etc., along with rice. Ingestible furikake, side dishes such as sausage, ham and kamaboko, desserts such as jelly and pudding, dairy products such as yogurt, ice cream and milk, confectioneries such as gummy candies, candy, chocolate and gum, drinks such as juice and drinks. Is mentioned.

【0024】この場合、アミラーゼ阻害剤の配合割合
は、食品全量に対して0.001〜100重量%、特に
0.01〜30重量%となるように配合することが好ま
しい。なお、上述したように、本発明のアミラーゼ阻害
剤は、味の点で問題がないので、本発明のアミラーゼ阻
害用組成物を食品として利用する際にも、味のマスキン
グの必要がなく、その製造に際して上記食品に適宜混ぜ
込む等の方法により製造することができる。
In this case, it is preferable that the amylase inhibitor is added in an amount of 0.001 to 100% by weight, particularly 0.01 to 30% by weight, based on the total amount of the food. As described above, the amylase inhibitor of the present invention has no problem in terms of taste, and therefore, when the composition for amylase inhibition of the present invention is used as a food, it is not necessary to mask the taste, It can be manufactured by a method of appropriately mixing it with the above-mentioned food during manufacturing.

【0025】[0025]

【発明の効果】本発明のアミラーゼ阻害剤は、従来より
食品、漢方薬等として広く用いられてきた桂皮から得ら
れるものであるので、人体に対する安全性に問題がな
く、そのアミラーゼ阻害活性が高いのみならず、桂皮に
特有の苦みや刺激臭がほとんどない。従って、本発明の
アミラーゼ阻害剤を有効成分として含有するアミラーゼ
阻害用組成物は、特別な味のマスキング処理を施すこと
なく、医薬品及び食品として好適に利用することができ
る。
Industrial Applicability Since the amylase inhibitor of the present invention is obtained from cinnamon bark which has been widely used as a food, a herbal medicine, etc., there is no problem in safety for human body and its amylase inhibitory activity is high. Moreover, there is almost no bitterness or irritating odor peculiar to cinnamon bark. Therefore, the amylase-inhibiting composition containing the amylase inhibitor of the present invention as an active ingredient can be suitably used as a pharmaceutical product and a food without any special taste masking treatment.

【0026】[0026]

【実施例】以下、実施例及び比較例を示して本発明を具
体的に説明するが、本発明は下記の実施例に制限される
ものではない。
EXAMPLES The present invention will be specifically described below with reference to examples and comparative examples, but the present invention is not limited to the following examples.

【0027】[実施例1]桂皮末(発売元:(株)ウチ
ダ和漢薬)100gをヘキサン500ml中に浸漬し、
室温にて3時間撹拌した後、濾過によってヘキサンを除
去した。この操作を2回繰り返し、脱油処理物を得た。
この脱油処理物を50容量%エタノール水溶液500m
l中に浸漬し、沸騰下で1時間抽出した。この操作を2
回繰り返し、抽出液を集めた。得られた抽出液をエバポ
レーターにて60℃で減圧濃縮し、凍結乾燥して抽出物
約6gを得た。なお、得られた抽出物は粉末状であっ
た。
[Example 1] 100 g of cinnamon powder (sold by: Uchida Wakan Yaku Co., Ltd.) was immersed in 500 ml of hexane,
After stirring at room temperature for 3 hours, hexane was removed by filtration. This operation was repeated twice to obtain a deoiled product.
This deoiled product is treated with a 50% by volume aqueous ethanol solution of 500 m.
It was immersed in 1 and extracted under boiling for 1 hour. This operation 2
Repeated times to collect the extract. The obtained extract was concentrated under reduced pressure at 60 ° C. by an evaporator and freeze-dried to obtain about 6 g of extract. The obtained extract was in powder form.

【0028】[実施例2]実施例1において、50容量
%エタノール水溶液500mlに代えて90容量%エタ
ノール水溶液500mlを用いる以外は実施例1と同様
に抽出処理を行い、得られた抽出液を凍結乾燥して、抽
出物約4gを得た。なお、得られた抽出物は塊状であっ
た。
[Example 2] The extraction treatment was carried out in the same manner as in Example 1 except that 500 ml of 90% by volume ethanol aqueous solution was used in place of 500 ml of 50% by volume aqueous ethanol solution, and the obtained extract was frozen. After drying, about 4 g of extract was obtained. In addition, the obtained extract was lumpy.

【0029】[実施例3]桂皮末(発売元:(株)ウチ
ダ和漢薬)100gを50容量%エタノール溶液500
ml中に浸漬し、沸騰下で1時間抽出する。この操作を
2回繰り返し、抽出液を集めた。得られた抽出液をエバ
ポレーターにて60℃で減圧濃縮し、凍結乾燥して抽出
物を得た。この抽出物をヘキサン100ml中に浸漬
し、室温にて3時間撹拌後、濾過によってヘキサンを除
去した。この操作を2回繰り返した後、乾燥し、脱油処
理した抽出物約6gを得た。なお、得られた抽出物は粉
末状であった。
[Example 3] 100 g of cinnamon powder (sold by: Uchida Wakan Yaku Co., Ltd.) in 50% by volume ethanol solution 500
Immerse in ml and extract under boiling for 1 hour. This operation was repeated twice to collect the extract. The obtained extract was concentrated under reduced pressure at 60 ° C with an evaporator and freeze-dried to obtain an extract. This extract was immersed in 100 ml of hexane, stirred at room temperature for 3 hours, and then hexane was removed by filtration. After repeating this operation twice, about 6 g of a dried and deoiled extract was obtained. The obtained extract was in powder form.

【0030】[比較例1]桂皮末(発売元:(株)ウチ
ダ和漢薬)100gを50容量%エタノール溶液500
ml中に浸漬し、沸騰下で1時間抽出する。この操作を
2回繰り返し、抽出液を集めた。得られた抽出液をエバ
ポレーターにて60℃で減圧濃縮し、凍結乾燥して抽出
物約7gを得た。
[Comparative Example 1] 100 g of cinnamon powder (sold by Uchida Wakan Yaku Co., Ltd.) in 50% by volume ethanol solution 500
Immerse in ml and extract under boiling for 1 hour. This operation was repeated twice to collect the extract. The obtained extract was concentrated under reduced pressure at 60 ° C. by an evaporator and freeze-dried to obtain about 7 g of extract.

【0031】[比較例2]桂皮末(発売元:(株)ウチ
ダ和漢薬)をそのまま用いた。
[Comparative Example 2] Cinnamon powder (sold by: Uchida Wakhan Co., Ltd.) was used as it was.

【0032】[比較例3]比較例1において、50容量
%エタノール水溶液の代わりに水を用いた以外は比較例
1と同様にして抽出物を得た。
[Comparative Example 3] An extract was obtained in the same manner as in Comparative Example 1 except that water was used instead of the 50% by volume aqueous ethanol solution in Comparative Example 1.

【0033】[比較例4]比較例1において、50容量
%エタノール水溶液の代わりにエタノールを用いた以外
は比較例1と同様にして抽出物を得た。
[Comparative Example 4] An extract was obtained in the same manner as in Comparative Example 1 except that ethanol was used in place of the 50% by volume aqueous ethanol solution in Comparative Example 1.

【0034】実施例1〜3、比較例1〜4の抽出物をメ
タノールに10mg/mlとなるよう溶かし、濾過した
ものについてα−アミラーゼ(枯草菌由来、発売元:
(株)和光純薬)活性阻害率を下記の測定法により測定
した。また、各抽出物の0.1重量%水溶液を調製し、
パネラーを5名として各水溶液の味の官能試験を行い、
下記の味の評価基準により評価(平均値)した。これら
の結果を表1に示す。α−アミラーゼ阻害活性の測定法 1)0.5重量%可溶性澱粉、20mMCaCl2、1
00mMNaClを含む50mM酢酸緩衝液(pH6.
5)に適当量のα−アミラーゼ酵素液(枯草菌由来)及
び検体20μlを加え、全量を0.5mlとする。(氷
浴中) 2)37℃で15分間インキュベートして反応を行い、
直ちに氷浴中にて反応を停止させる。 3)ヨウ素試液(1/6000Mヨウ素、1/600M
ヨウ化カリウム、1/600M塩酸)5mlを加え、7
00nmにおける吸光度を測定する。対照として、酵素
を入れないもの(対照1:OD700=約1.2)、更に
酵素を入れたもの(対照2:OD700=約0.2)を同
時に測定する。 4)抑制率は下記式から算出する。 抑制率(%)=(検体−対照2)÷(対照1−対照2)
×100味の評価基準 ○:桂皮特有の苦みや刺激臭をほとんど感じない △:桂皮特有の苦みや刺激臭を弱く感じる ×:桂皮特有の苦みや刺激臭を強く感じる
The extracts of Examples 1 to 3 and Comparative Examples 1 to 4 were dissolved in methanol to a concentration of 10 mg / ml and filtered to obtain α-amylase (derived from Bacillus subtilis, sold by:
Wako Pure Chemical Industries, Ltd.) The activity inhibition rate was measured by the following measuring method. Also, prepare a 0.1 wt% aqueous solution of each extract,
Sensory test of the taste of each aqueous solution with 5 panelists,
The evaluation was made (average value) according to the following taste evaluation criteria. Table 1 shows the results. Method for measuring α-amylase inhibitory activity 1) 0.5 wt% soluble starch, 20 mM CaCl 2 , 1
50 mM acetate buffer (pH 6.
An appropriate amount of α-amylase enzyme solution (derived from Bacillus subtilis) and 20 μl of a sample are added to 5) to make the total amount 0.5 ml. (In ice bath) 2) Incubate at 37 ° C for 15 minutes to carry out reaction,
Immediately stop the reaction in an ice bath. 3) Iodine reagent (1 / 6000M iodine, 1 / 600M
Add 5 ml of potassium iodide and 1/600 M hydrochloric acid, and add 7
The absorbance at 00 nm is measured. As controls, those without enzyme (Control 1: OD 700 = about 1.2) and those with further enzyme (Control 2: OD 700 = about 0.2) are measured at the same time. 4) The suppression rate is calculated from the following formula. Inhibition rate (%) = (Sample-Control 2) / (Control 1-Control 2)
× 100 Evaluation criteria of taste ○: Almost no bitterness or irritating odor peculiar to cinnamon is felt Δ: Bitterness or irritating odor peculiar to cinnamon is weak ×: Strong bitterness or irritating odor peculiar to cinnamon is strongly felt

【0035】[0035]

【表1】 [Table 1]

【0036】表1によれば、本発明のアミラーゼ阻害剤
(抽出物)は、アミラーゼ阻害活性が高く、且つ桂皮特
有の苦みや刺激臭味がなく、味が改善されているのに対
し、桂皮そのもの(比較例2)、水又はエタノール抽出
処理のみ行った場合(比較例3、4)は、アミラーゼ阻
害活性が低く、且つ桂皮特有の苦みや刺激臭味を有し、
脱油処理を行わない場合(比較例1)は、アミラーゼ阻
害活性は高いが、桂皮特有の苦みや刺激臭を有すること
が認められる。
According to Table 1, the amylase inhibitor (extract) of the present invention has a high amylase inhibitory activity and does not have the bitterness or pungent odor characteristic of cinnamon bark, while the taste is improved. As such (Comparative Example 2), when only water or ethanol extraction treatment was carried out (Comparative Examples 3 and 4), the amylase inhibitory activity was low, and there was bitterness and irritating odor characteristic of cinnamon bark,
When the oil removal treatment is not performed (Comparative Example 1), the amylase inhibitory activity is high, but it is recognized that the cinnamon bark has a bitter taste and an irritating odor.

【0037】次に、動物(SD系ラット、雄、4週令)
を一群6匹として、上記実施例1で得られた抽出物を飼
料に2%配合し、2週間飼育した群を桂皮群、抽出物無
添加の飼料で同様に飼育した群をコントロール群とし
た。そして、2週間飼育後の各群の動物の体重増加量と
飼料摂取量から得られる飼料効率を下記式により求める
と共に、各群の動物の体重量と副睾丸脂肪組織重量から
脂肪率を求めた。結果を表2に示す。 飼料効率(%)=体重増加量(g)÷飼料摂取量(g)
×100
Next, animal (SD rat, male, 4 weeks old)
6 groups per group, 2% of the extract obtained in the above Example 1 was mixed in the feed, and the group fed for 2 weeks was used as the cinnamon group, and the group fed in the same manner with the feed containing no extract was used as the control group. . Then, the feed efficiency obtained from the weight gain and the feed intake of the animals in each group after being raised for 2 weeks was obtained by the following formula, and the fat percentage was obtained from the body weight of the animals in each group and the epididymal adipose tissue weight. . Table 2 shows the results. Feed efficiency (%) = weight gain (g) ÷ feed intake (g)
× 100

【0038】[0038]

【表2】 [Table 2]

【0039】また、上記実施例1で得られた抽出物を、
女性パネラー3名(A、B、C)が1日3回(315m
g/日)食前服用した。これを30日間実施し、その間
の体重変化を測定した。結果を図1に示す。
Further, the extract obtained in the above Example 1 was
3 female panelists (A, B, C) 3 times a day (315m
g / day) Taken before meals. This was carried out for 30 days, and the change in body weight during that period was measured. The results are shown in FIG.

【0040】[実施例4]実施例2で得られた抽出物3
50mgを熱湯250mlに分散、溶解し、更にコーヒ
ー粉末6.0g、エリスリトール5.0gを加え、最後
にゼラチン5.0gを加えた後、冷蔵保存し、コーヒー
ゼリー(アミラーゼ阻害用組成物)を得た。
[Example 4] Extract 3 obtained in Example 2
Disperse and dissolve 50 mg in 250 ml of boiling water, add 6.0 g of coffee powder and 5.0 g of erythritol, and finally add 5.0 g of gelatin, and store in refrigeration to obtain coffee jelly (composition for amylase inhibition). It was

【0041】[実施例5]実施例1で得られた抽出物3
00mgと小麦粉120g、エリスリトール10g、シ
ョートニング15g、全卵粉0.5g、食塩1g、炭酸
水素ナトリウム0.6g、炭酸アンモニウム0.75g
及び水20gを用いて、常法によりドウを作成し、成
型、焙焼してビスケット(アミラーゼ阻害用組成物)を
製造した。
[Example 5] Extract 3 obtained in Example 1
00 mg and flour 120 g, erythritol 10 g, shortening 15 g, whole egg powder 0.5 g, salt 1 g, sodium hydrogen carbonate 0.6 g, ammonium carbonate 0.75 g
Using 20 g of water and 20 g of water, a dough was prepared by a conventional method, molded and roasted to produce a biscuit (composition for amylase inhibition).

【0042】実施例4、5のアミラーゼ阻害用組成物に
ついて、パネラー5名として各組成物の味の官能試験を
行い、上記の味の評価基準により評価した。結果を表3
に示す。
The amylase-inhibiting compositions of Examples 4 and 5 were subjected to a sensory test of the taste of each composition by 5 panelists, and evaluated according to the above-mentioned taste evaluation criteria. Table 3 shows the results
Shown in

【0043】[0043]

【表3】 [Table 3]

【0044】表3によれば、本発明のアミラーゼ阻害用
組成物は、特にアミラーゼ阻害剤自体の味が飲食の際に
大きく影響する食品であっても、その味に問題がないこ
とが認められる。
According to Table 3, it is recognized that the composition for amylase inhibition of the present invention has no problem in the taste even if the taste of the amylase inhibitor itself has a great influence on eating and drinking. .

【図面の簡単な説明】[Brief description of drawings]

【図1】実施例1で得られた本発明のアミラーゼ阻害剤
を服用した場合の体重変化を示すグラフである。
FIG. 1 is a graph showing changes in body weight when the amylase inhibitor of the present invention obtained in Example 1 was taken.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 宮本 園子 東京都墨田区本所1丁目3番7号 ライオ ン株式会社内 (72)発明者 大関 秀明 東京都墨田区本所1丁目3番7号 ライオ ン株式会社内 ─────────────────────────────────────────────────── ─── Continuation of front page (72) Inventor Sonoko Miyamoto 1-3-7, Sumida-ku, Tokyo Lion Corporation (72) Inventor Hideaki Ozeki 1-3-7, Sumida-ku, Tokyo Within Lion Corporation

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 桂皮の脱油処理及び含水エタノール溶液
による抽出処理物を有効成分とすることを特徴とするア
ミラーゼ阻害剤。
1. An amylase inhibitor, which comprises a deoiled cinnamon and an extract treated with an aqueous ethanol solution as active ingredients.
【請求項2】 医薬品又は食品として利用されるアミラ
ーゼ阻害用組成物であって、請求項1記載のアミラーゼ
阻害剤を有効成分として含有することを特徴とするアミ
ラーゼ阻害用組成物。
2. A composition for amylase inhibition, which is used as a medicine or food, and which contains the amylase inhibitor according to claim 1 as an active ingredient.
JP7215368A 1995-08-01 1995-08-01 Inhibitor of amylase and composition for inhibiting amylase Pending JPH0940572A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP7215368A JPH0940572A (en) 1995-08-01 1995-08-01 Inhibitor of amylase and composition for inhibiting amylase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7215368A JPH0940572A (en) 1995-08-01 1995-08-01 Inhibitor of amylase and composition for inhibiting amylase

Publications (1)

Publication Number Publication Date
JPH0940572A true JPH0940572A (en) 1997-02-10

Family

ID=16671144

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7215368A Pending JPH0940572A (en) 1995-08-01 1995-08-01 Inhibitor of amylase and composition for inhibiting amylase

Country Status (1)

Country Link
JP (1) JPH0940572A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000044484A (en) * 1998-07-31 2000-02-15 Higashimaru Shoyu Co Ltd Amylase inhibition-active substance and its use
JP2001299242A (en) * 2000-04-28 2001-10-30 Kanebo Ltd Food containing gelling agent and method for producing the same
JPWO2002047699A1 (en) * 2000-12-12 2004-04-15 鐘淵化学工業株式会社 Composition for preventing or ameliorating multiple risk factor syndrome
JP2006199647A (en) * 2005-01-21 2006-08-03 Japan Health Science Foundation Adipocyte differentiation regulating agent
JP2007518420A (en) * 2004-01-26 2007-07-12 エヌ.ブイ.・ヌートリシア Improved semi-solid food based on inhibiting amylase-induced starch degradation and method for producing the same
JP2009142271A (en) * 2007-11-22 2009-07-02 Taisho Pharmaceutical Co Ltd Beverage
JP2009142272A (en) * 2007-11-22 2009-07-02 Taisho Pharmaceutical Co Ltd Beverage

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000044484A (en) * 1998-07-31 2000-02-15 Higashimaru Shoyu Co Ltd Amylase inhibition-active substance and its use
JP2001299242A (en) * 2000-04-28 2001-10-30 Kanebo Ltd Food containing gelling agent and method for producing the same
JPWO2002047699A1 (en) * 2000-12-12 2004-04-15 鐘淵化学工業株式会社 Composition for preventing or ameliorating multiple risk factor syndrome
US8071141B2 (en) 2000-12-12 2011-12-06 Kaneka Corporation Compositions for preventing or ameliorating multiple risk factor syndromes
JP2007518420A (en) * 2004-01-26 2007-07-12 エヌ.ブイ.・ヌートリシア Improved semi-solid food based on inhibiting amylase-induced starch degradation and method for producing the same
JP2006199647A (en) * 2005-01-21 2006-08-03 Japan Health Science Foundation Adipocyte differentiation regulating agent
JP4742204B2 (en) * 2005-01-21 2011-08-10 財団法人ヒューマンサイエンス振興財団 Adipocyte differentiation regulator
JP2009142271A (en) * 2007-11-22 2009-07-02 Taisho Pharmaceutical Co Ltd Beverage
JP2009142272A (en) * 2007-11-22 2009-07-02 Taisho Pharmaceutical Co Ltd Beverage

Similar Documents

Publication Publication Date Title
JP3018013B2 (en) α-amylase activity inhibitor
TWI329516B (en) Composition for preventing or ameliorating multiple risk factor syndromes and visceral fat-type obesity
CN100566723C (en) Carbohydrase inhibitor and application thereof derived from the acorn-cup plant
JPH09291039A (en) Antiobestic medicine comprising procyanidin as active ingredient
RU2350120C1 (en) Nutrition additive and foodstuff containing potato painted in purple colour for patients, suffering from adiposity (versions)
JP2002154977A (en) Composition for drinking and eating
JPH0940572A (en) Inhibitor of amylase and composition for inhibiting amylase
JP4499209B2 (en) Obesity prevention and improvement agent
CA2073326A1 (en) Method of inhibiting sucrase activity
WO2008018139A1 (en) Antiobesity composition containing component originating in the bark of tree belonging to the genus acacia
WO2005056034A1 (en) Alga extract and lipase inhibitor containing the same
JP3178822B2 (en) 3α-hydroxysteroid dehydrogenase inhibitory activator and hyaluronidase inhibitory activator
JP2008531552A (en) Mixed herbal extract of ripening yellow and five peels and composition for prevention and treatment of osteoporosis containing the same as an active ingredient
WO2020122373A1 (en) Composition comprising glycyrrhiza uralensis extract as active ingredient for prevention, alleviation, or treatment of late-onset hypogonadism syndrome
JP4542765B2 (en) Enzyme inhibitor
JP4334834B2 (en) Bladder function improving agent or therapeutic agent for dysuria
JPH0940573A (en) Inhibitor of amylase and composition for inhibiting amylase
JP4610730B2 (en) Composition for calcium supplementation
JP3345650B2 (en) Hypertension inhibitor
JP2002255832A (en) Mineral absorption-promoting agent and anemia- improving agent
JP2002053475A (en) Glucosidase inhibitor and food or beverage including the same
KR102487651B1 (en) A composition for preventing, improving or treating sarcopenia comprising extracts of wheat sprout
JP2003277273A (en) Mineral absorption-promoting agent
JP4727790B2 (en) Anti-obesity agent
KR102380295B1 (en) A composition for preventing, improving or treating sarcopenia comprising extracts of oat